138 related articles for article (PubMed ID: 16322444)
1. Immunology. Tipping the scales toward more effective antibodies.
Woof JM
Science; 2005 Dec; 310(5753):1442-3. PubMed ID: 16322444
[No Abstract] [Full Text] [Related]
2. Antibody-mediated modulation of immune responses.
Nimmerjahn F; Ravetch JV
Immunol Rev; 2010 Jul; 236():265-75. PubMed ID: 20636822
[TBL] [Abstract][Full Text] [Related]
3. Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?
Dimitrov JD; Bayry J; Sibéril S; Kaveri SV
Nephrol Dial Transplant; 2007 May; 22(5):1301-4. PubMed ID: 17298999
[No Abstract] [Full Text] [Related]
4. Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.
Vitetta ES; Uhr JW
Cancer Res; 1994 Oct; 54(20):5301-9. PubMed ID: 7923157
[No Abstract] [Full Text] [Related]
5. [Reactivity of platelet-specific and HLA antibodies with chloroquine-treated thrombocytes].
Langenscheidt F; Kiefel V; Santoso S; Nau A; Mueller-Eckhardt C
Beitr Infusionther Klin Ernahr; 1987; 18():382-4. PubMed ID: 3439998
[No Abstract] [Full Text] [Related]
6. [Reactivity of the monoclonal antibody ALT-04 and an experimental study on its use in tumor-localization].
Yu YB
Zhonghua Yi Xue Za Zhi; 1986 Dec; 66(12):742-5. PubMed ID: 3103890
[No Abstract] [Full Text] [Related]
7. [Some diagnostic and therapeutic applications of the monoclonal antibodies].
Melino G; Plebani A; Riches P
Clin Ter; 1984 Jun; 109(5):455-65. PubMed ID: 6236937
[No Abstract] [Full Text] [Related]
8. Functions of antibodies in the regulation of B cell responses in vivo.
Heyman B
Springer Semin Immunopathol; 2001 Dec; 23(4):421-32. PubMed ID: 11826618
[No Abstract] [Full Text] [Related]
9. Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials.
Béliard R
Transfus Clin Biol; 2006; 13(1-2):58-64. PubMed ID: 16580863
[TBL] [Abstract][Full Text] [Related]
10. Engineering therapeutic monoclonal antibodies.
Liu XY; Pop LM; Vitetta ES
Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
[TBL] [Abstract][Full Text] [Related]
11. Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.
Embleton MJ; Gunn B; Byers VS; Baldwin RW
Transplant Proc; 1981 Dec; 13(4):1966-9. PubMed ID: 6949387
[No Abstract] [Full Text] [Related]
12. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
13. Can super-antibody drugs be tamed?
Nature; 2006 Apr; 440(7086):855-6. PubMed ID: 16612349
[No Abstract] [Full Text] [Related]
14. Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Johnson S; Koenig S; Bonvini E
Adv Enzyme Regul; 2008; 48():152-64. PubMed ID: 18177741
[No Abstract] [Full Text] [Related]
15. Production and characterization of a monoclonal antibody against an antigen on the surface of non-small cell carcinoma of the lung.
Sharifzadeh S; Modjtahedi H; Jedi Tehrani M; Bayat A; Ghaderi A
Iran J Immunol; 2007 Dec; 4(4):206-14. PubMed ID: 18057578
[TBL] [Abstract][Full Text] [Related]
16. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
Bazin R; Lemieux R; Tremblay T
Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
[TBL] [Abstract][Full Text] [Related]
17. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Peggs KS; Quezada SA; Korman AJ; Allison JP
Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
[TBL] [Abstract][Full Text] [Related]
18. Possible applications of antibodies or their genes in cancer therapy.
Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma receptors.
Cohen-Solal JF; Cassard L; Fridman WH; Sautès-Fridman C
Immunol Lett; 2004 Apr; 92(3):199-205. PubMed ID: 15081612
[No Abstract] [Full Text] [Related]
20. Divergent immunoglobulin g subclass activity through selective Fc receptor binding.
Nimmerjahn F; Ravetch JV
Science; 2005 Dec; 310(5753):1510-2. PubMed ID: 16322460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
